Cancer Society Mourns the Loss of Prof. Avraham Koten
01.07.23 00:00
The Cancer Society, along with its executive committee, managers, employees, and volunteers, is grieving the untimely passing of esteemed oncologist Prof. Avraham Koten. Prof. Koten was also the chairman of the Cancer Society, making his loss deeply felt by all those associated with the organization.
Prof. Avraham Koten’s journey in the field of oncology began as an intern at Rambam Medical College. Over the course of 40 years, he dedicated himself to the medical profession, eventually retiring as the director of the system. In addition to his work at Rambam, Prof. Koten was an active member of the National Oncology Council, serving on various professional committees.
One of the major highlights of his career was his position as the chairman of the committee for treatment by protons in Israel. Alongside a team of Israeli and international experts, Prof. Koten recommended the establishment of an academic proton center in a public hospital. Construction of this center is currently underway and is expected to be operational in the near future. The Cancer Society has been providing valuable assistance to this ambitious project.
Moshe Bar Chaim, the director general of the Cancer Society, paid tribute to Prof. Koten, highlighting his significant contributions to radiotherapy in Israel. In 2019, Prof. Koten voluntarily took up the role of chairman of the Cancer Society, spearheading numerous initiatives in the field. His dedication to the society and the patients it serves was evident throughout his career. Prof. Koten’s professionalism and expertise will be greatly missed, and he will be remembered with immense appreciation.
The funeral service for Prof. Avraham Koten will be held on Sunday, the 13th of Tammuz, July 2, 2023, in Haifa. Detailed information regarding the funeral arrangements will be shared with the public shortly.
The Cancer Society and the medical community at large have suffered a great loss with the departure of Prof. Avraham Koten. His legacy will continue to inspire and guide future generations of oncologists and medical professionals, ensuring his impact on cancer treatment in Israel endures.